Hence, these data implied that miR-155-5p and CTHRC1 were considered not only new molecular biomarkers in predicting the aggressive biology of HCC but also novel therapeutic targets to guide effective treatment for HCC patients. The gene discussed is CTHRC1; the disease is hepatocellular carcinoma.